Cargando…

Physiologically-Relevant Modes of Membrane Interactions by the Human Antimicrobial Peptide, LL-37, Revealed by SFG Experiments

Antimicrobial peptides (AMPs) could become the next generation antibiotic compounds which can overcome bacterial resistance by disrupting cell membranes and it is essential to determine the factors underlying its mechanism of action. Although high-resolution NMR and other biological studies have pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Bei, Soblosky, Lauren, Nguyen, Khoi, Geng, Junqing, Yu, Xinglong, Ramamoorthy, Ayyalusamy, Chen, Zhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655398/ https://www.ncbi.nlm.nih.gov/pubmed/23676762 http://dx.doi.org/10.1038/srep01854

Ejemplares similares

Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells
por: Muñoz, Mindy, et al.
Publicado: (2016)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
por: Kang, Jason, et al.
Publicado: (2019)

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
por: Mücke, Pierre-Alexander, et al.
Publicado: (2020)

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
por: Ridyard, Kylen E., et al.
Publicado: (2021)

Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis
por: SZABÓ, Lilla, et al.
Publicado: (2023)

LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023)

Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
por: Reinholz, Markus, et al.
Publicado: (2012)

Salivary concentration of the antimicrobial peptide LL-37 in patients with oral lichen planus
por: Davidopoulou, Sotiria, et al.
Publicado: (2014)

The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs
por: Kuroda, Kengo, et al.
Publicado: (2015)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
por: Babikir, Ibrahim H., et al.
Publicado: (2018)

Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health
por: Khurshid, Zohaib, et al.
Publicado: (2017)

Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy
por: Findlay, Emily Gwyer, et al.
Publicado: (2019)

Oxidative stress induced in E. coli by the human antimicrobial peptide LL-37
por: Choi, Heejun, et al.
Publicado: (2017)

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
por: Pahar, Bapi, et al.
Publicado: (2020)

Cathelicidins PMAP-36, LL-37 and CATH-2 are similar peptides with different modes of action
por: Scheenstra, Maaike R., et al.
Publicado: (2019)

OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii
por: Lin, Ming-Feng, et al.
Publicado: (2015)

Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
por: Majewski, Karol, et al.
Publicado: (2018)

SP-LL-37, human antimicrobial peptide, enhances disease resistance in transgenic rice
por: Lee, In Hye, et al.
Publicado: (2017)

Evaluation of antimicrobial peptide LL-37 for treatment of Staphylococcus aureus biofilm on titanium plate
por: Wei, Jiantong, et al.
Publicado: (2021)

The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds
por: Duplantier, Allen J., et al.
Publicado: (2013)

Heparan Sulfate Proteoglycan–Involving Immunomodulation by Cathelicidin Antimicrobial Peptides LL-37 and PR-39
por: Kaneider, Nicole C., et al.
Publicado: (2007)

The Human Antimicrobial Peptides Dermcidin and LL-37 Show Novel Distinct Pathways in Membrane Interactions
por: Zeth, Kornelius, et al.
Publicado: (2017)

Heterogeneous absorption of antimicrobial peptide LL37 in Escherichia coli cells enhances population survivability
por: Snoussi, Mehdi, et al.
Publicado: (2018)

OmpA-Like Proteins of Porphyromonas gingivalis Mediate Resistance to the Antimicrobial Peptide LL-37
por: Horie, Toshi, et al.
Publicado: (2018)

The Human LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure
por: Engelberg, Yizhaq, et al.
Publicado: (2020)

Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model
por: Nagaoka, Isao, et al.
Publicado: (2020)

Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability
por: Gunasekera, Sunithi, et al.
Publicado: (2020)

Long-Lasting Stable Expression of Human LL-37 Antimicrobial Peptide in Transgenic Barley Plants
por: Mirzaee, Malihe, et al.
Publicado: (2021)

Self-assembly of glycerol monooleate with the antimicrobial peptide LL-37: a molecular dynamics study
por: Innocenti Malini, R., et al.
Publicado: (2020)

HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients
por: Mohanty, Soumitra, et al.
Publicado: (2021)

Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37
por: Zhuo, Haiwei, et al.
Publicado: (2022)

Cord blood antimicrobial peptide LL37 levels in preterm neonates and association with preterm complications
por: Ren, Zhuxiao, et al.
Publicado: (2022)

Enhancement of the activity of the antimicrobial peptides HNP1 and LL-37 by bovine pancreatic ribonuclease A
por: Ericksen, Bryan
Publicado: (2023)

Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37
por: Krishnamoorthy, Rajavenkatesh, et al.
Publicado: (2023)

Transformation of Human Cathelicidin LL-37 into Selective, Stable, and Potent Antimicrobial Compounds
por: Wang, Guangshun, et al.
Publicado: (2014)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
por: Zhang, Zhifang, et al.
Publicado: (2019)

Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands
por: Morizane, Shin, et al.
Publicado: (2011)

Antimicrobial Cathelicidin Peptide LL-37 Inhibits the LPS/ATP-Induced Pyroptosis of Macrophages by Dual Mechanism
por: Hu, Zhongshuang, et al.
Publicado: (2014)

Molecular Dynamics Simulations of Human Antimicrobial Peptide LL-37 in Model POPC and POPG Lipid Bilayers
por: Zhao, Liling, et al.
Publicado: (2018)

Rigidification of the Escherichia coli cytoplasm by the human antimicrobial peptide LL-37 revealed by superresolution fluorescence microscopy
por: Zhu, Yanyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k3cnv2fofm7r9d0cc4smosciag